Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.
about
How could patient reported outcomes improve patient management in chronic myeloid leukemia?Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative studyQuality of Life and Long-Term Therapy in Patients with Chronic Myeloid LeukemiaTherapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS surveyClinical efficacy and safety of imatinib in the management of Ph(+) chronic myeloid or acute lymphoblastic leukemia in Chinese patients.Variables associated with patient-reported outcomes in persons with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy.Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment.BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: do we know enough?Treatment satisfaction with different weight loss methods among respondents with obesity.Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries.Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia.Symptom Burden and Quality of Life Issues among Patients of Chronic Myeloid Leukemia on Long-term Imatinib TherapyFirst-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI.Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.Quality of life of chronic myeloid leukemia patients in Brazil: ability to work as a key factor.Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy.Dasatinib dose management for the treatment of chronic myeloid leukemia.A Phase 1, Randomized, Single-Dose Crossover Pharmacokinetic Study to Investigate the Effect of Food Intake on Absorption of Orteronel (TAK-700) in Healthy Male Subjects.Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.
P2860
Q30241092-AB727310-516A-4682-B7DE-02041A5B8E82Q33813279-BB1B119C-8CDD-41F5-A896-B81884D9C313Q36880864-85D8F93B-4971-4E77-BCF6-A7EA4DDE5AA9Q37027674-FAD77D74-0F08-408A-8DC8-C00406ACC21EQ37630453-3B125074-B6C9-46A9-9E49-C020E96489B1Q38934423-8817D625-860A-4988-BB41-30E88FC8176EQ38989447-EC54A1AC-6F5D-4466-8251-860A4D26A976Q39350678-565898F5-6A5E-494F-9785-284C20006CD0Q39797514-965390F2-75DC-4CE0-BD7C-CDA9F8A1C93AQ39894236-EB1A19A2-66C8-454D-8A8F-4039B00AA078Q40294098-E42B6B8C-EA31-44F3-B53B-FD169FBAEDDEQ41203712-C8C01898-A5CF-470C-8129-848816789AEFQ41601810-F6766179-8DA8-4A60-9BBD-DDB92375A5DBQ47917650-DCDD6E36-F4FE-4146-B895-BEB18D4CCCA3Q47929120-8758E0FA-6EB3-49EC-AC78-AC51924198DFQ48082559-C27F1FAF-0261-4E3D-8D7A-38117566B74EQ48124245-DC9689B0-A604-4F71-9809-EAE51102CC0EQ48165102-7ED071DC-940A-4F39-8499-5148E275D7A3Q51284848-0700FF25-7A00-4BC1-8D30-82735B087DFAQ52677126-7F773538-7EAD-4702-9B88-F86839615278
P2860
Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic myeloid leukemia (CML) ...... rom the patient's perspective.
@en
Chronic myeloid leukemia (CML) ...... rom the patient's perspective.
@nl
type
label
Chronic myeloid leukemia (CML) ...... rom the patient's perspective.
@en
Chronic myeloid leukemia (CML) ...... rom the patient's perspective.
@nl
prefLabel
Chronic myeloid leukemia (CML) ...... rom the patient's perspective.
@en
Chronic myeloid leukemia (CML) ...... rom the patient's perspective.
@nl
P2093
P2860
P356
P1476
Chronic myeloid leukemia (CML) ...... rom the patient's perspective.
@en
P2093
Alyson B Moadel
Amir Goren
Catherine C Davis
Diana R Chirovsky
Eduardo Olavarria
Ishan Hirji
Shaloo Gupta
Timothy W Victor
P2860
P2888
P356
10.1186/1477-7525-11-167
P577
2013-10-08T00:00:00Z
P5875
P6179
1008466666